TOBI can help people with cystic fibrosis manage Pseudomonas aeruginosa (Pa) infections.
TOBI® (Tobramycin Inhalation Solution, USP)
is the only FDA-approved inhaled antibiotic for treating Pa
in cystic fibrosis. TOBI has been on the market for 10 years. It is approved for people aged 6 and over with a lung function within a certain range.
It can help people with cystic fibrosis by
improving lung function, reducing the number of days in the
hospital and the need for IV antibiotics. As someone living
with or caring for someone with cystic fibrosis, it's
important to learn the basics about TOBI, like:
